Treatment of inflammatory diseases using placental stem cells

Details for Australian Patent Application No. 2008216749 (hide)

Owner Anthrogenesis Corporation

Inventors Faleck, Herbert; Wang, Jia-Lun; Hariri, Robert J.; Edinger, James W.; Ye, Qian

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008216749

PCT Pub. Number WO2008/100498

Priority 60/901,067 12.02.07 US

Filing date 12 February 2008

Wipo publication date 21 August 2008

International Classifications

A61K 35/44 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Eyes

A61K 35/50 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 35/64 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

Event Publications

3 September 2009 PCT application entered the National Phase

  PCT publication WO2008/100498 Priority application(s): WO2008/100498

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008216757-Remotely activatable locator system and method

2008216748-Hepatocytes and chondrocytes from adherent placental stem cells; and CD34+, CD45placental stem cellenriched cell populations